Aspen Process Pulse – Enabling Real-Time Response
Align and improve your product to market demands as you optimize processes, monitor all raw materials and ensure superior quality. Additionally, take PAT to the shop floor.
Get early and accurate warning of when an asset failure will occur, how the failure will occur and what to do about it.
Identify the real underlying sources of variation in production processes that impact reliability and quality.
Model, predict and optimize processes using multivariate statistical analysis and interactive visualizations.
Solve complex problems with explorative, multivariate analysis of hyperspectral images.
Pharma companies continue to strive for tight control of critical quality attributes (CQAs). When Ferring Pharmaceuticals wanted to move from batch to continuous manufacturing, they found that laborat...On Demand Webinar
Pharmaceutical companies, CDMOs and CMOs face growing pressures to deliver more products at a lower cost while ensuring the quality and security of supply. Advanced PAT technologies address these chal...On Demand Webinar
Pharmaceutical companies, CDMOs and CMOs continue to grapple with the tension between meeting the demand for increasingly diverse pharmaceutical products and the escalating challenges in ensuring supp...White Paper
In this article from European Pharmaceutical Review, David Leitham, Senior Vice President and General Manager at AspenTech®, explains how implementing PAT pushes the industry towards Pharma 4.0. Downl...Article
While traditional reaction monitoring strategies have been effective at maintaining process safety and consistency, new developments are driving additional benefits like increased speed to market, red...On Demand Webinar
Batch processing requires supremely accurate monitoring to ensure successful batch completion. In the case of deviations, the ability to prevent unwanted process behavior from happening is critical to...On Demand Webinar
If faced with inhomogeneous blends, manufacturers lose money and valuable time. Not to mention the possible risks of reblends and regulatory citations.On Demand Webinar